Mr Robert Purbrick
Qualifications
MBChB (Hons), FRCOphth
GMC number: 6099473
Practising since: 2004
Specialties
Ophthalmology, Medical Ophthalmology, Ophthalmic Surgery
Consultation times
- Weekly Wednesday AM (Brighton)
- Weekly Monday AM (Haywards Heath)
- Overview
About
Robert Purbrick is a Consultant Ophthalmologist based in Brighton and Haywards Heath
He works as an NHS Consultant at Sussex Eye Hospital, Brighton and Sussex University Hospitals NHS Trust, where he is Clinical Lead for the age-related macular degeneration (AMD) service and Diabetic Eye Screening Programme.
Robert has subspecialty expertise in Medical Retina. He qualified from Liverpool Medical School in 2004 and carried out his postgraduate ophthalmology training in London, Liverpool and Oxford.
Robert has a special interest in cataract surgery and the management of retinal diseases including age-related macular degeneration (AMD), diabetic eye disease, retinal vascular occlusions, and central serous retinopathy (CSR).
Robert has completed comprehensive specialty training in ophthalmology as per the Royal College of Ophthalmologists’ postgraduate curriculum.
Special interests
- Cataract surgery
- Age-related macular degeneration (AMD)
- Diabetic eye disease
- Retinal vascular occlusions
- Disorders of the retina and macula
- General ophthalmology
- YAG laser treatment (Brighton only)
- Intravitreal injections
Treatments and tests offered by Mr Robert Purbrick at Nuffield Health
- Eyelid cyst removal
- Visual field testing
- YAG Capsulotomy
- Cataract Surgery
Locations Mr Robert Purbrick works with
Related experience
Research
Robert spent two years as a Clinical Research Fellow at the Nuffield Laboratory of Ophthalmology, University of Oxford, investigating the effect of ocular diseases on sleep and circadian rhythms. He is currently enrolled as a postgraduate student at the Institute of Ophthalmology, University College London, completing his MD(Res) thesis.
He continues to research and publish in many aspects of ophthalmology, including diabetic retinopathy, ocular toxicity of drugs, medical education, retinal imaging, the ageing eye, glaucoma diagnosis, treatment of age-related macular degeneration (AMD), complications of cataract surgery, and the patients’ role in the decision-making process.
Robert is a Principal Investigator for CLARITY, a clinical trial investigating the efficacy of intravitreal anti-VEGF injections versus laser for the treatment of proliferative diabetic retinopathy.
Memberships
- British Medical Association
- Royal College of Ophthalmologists
- Royal College of Surgeons of Edinburgh
Other posts held
- Sussex Eye Hospital, BSUH NHS Trust
- Consultant Ophthalmologist
Insurers Mr Robert Purbrick works with
Mr Robert Purbrick works with the following private medical insurance providers:
- AXA Health
- Bupa
- APRIL
- Aviva Health
- Cigna
- Exeter Family Friendly
- Freedom Health
- Medical Care Direct
- Simplyhealth
- Universal Provident
- Westfield Health WPA
Declaration
Mr Robert Purbrick does not hold a share or financial interest in this hospital, another Nuffield Health hospital or the company.
Mr Robert Purbrick has the following interest in equipment used at this hospital or another Nuffield Health hospital:
Mr Purbrick owns 33.3% share of an Optovue Avanti OCT machine (Haag-Streit) which is located at Nuffield Health Brighton Hospital & Nuffield Health Haywards Heath Hospital.
Mr Robert Purbrick does not hold any paid advisory role(s) at this hospital or on behalf of Nuffield Health.